Yoko Warabi

499 total citations
26 papers, 361 citations indexed

About

Yoko Warabi is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Yoko Warabi has authored 26 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 12 papers in Pathology and Forensic Medicine and 7 papers in Rheumatology. Recurrent topics in Yoko Warabi's work include Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (10 papers) and Systemic Lupus Erythematosus Research (5 papers). Yoko Warabi is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (10 papers) and Systemic Lupus Erythematosus Research (5 papers). Yoko Warabi collaborates with scholars based in Japan and United States. Yoko Warabi's co-authors include Hideaki Hayashi, Yoh Matsumoto, Shiro Matsubara, Toshio Shimizu, Motoyoshi Yamazaki, Masahiro Nagao, Toshiyuki Takahashi, Jiro Idezuka, Eiji Isozaki and Toshio Mizutani and has published in prestigious journals such as BioMed Research International, Journal of the Neurological Sciences and Journal of Neurology.

In The Last Decade

Yoko Warabi

20 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Warabi Japan 10 221 195 85 62 51 26 361
P. Adam Czechia 9 121 0.5× 115 0.6× 32 0.4× 22 0.4× 29 0.6× 26 293
Courtney Casserly Canada 7 181 0.8× 74 0.4× 52 0.6× 35 0.6× 23 0.5× 22 281
Abir Wahab France 6 226 1.0× 241 1.2× 15 0.2× 27 0.4× 204 4.0× 13 436
Ondřej Sobek Czechia 9 86 0.4× 89 0.5× 21 0.2× 20 0.3× 18 0.4× 23 236
Tomohiko Kusuhara Japan 10 53 0.2× 101 0.5× 43 0.5× 12 0.2× 43 0.8× 14 314
Ana Inês Martins Portugal 10 77 0.3× 102 0.5× 10 0.1× 40 0.6× 31 0.6× 29 383
Preeti Patil Chhablani India 10 65 0.3× 96 0.5× 19 0.2× 13 0.2× 29 0.6× 26 311
Michi Kawamoto Japan 11 28 0.1× 160 0.8× 48 0.6× 24 0.4× 36 0.7× 66 383
Naoya Minami Japan 11 104 0.5× 262 1.3× 11 0.1× 79 1.3× 110 2.2× 36 401
Daniel Dahlberg Norway 13 27 0.1× 118 0.6× 24 0.3× 16 0.3× 42 0.8× 28 367

Countries citing papers authored by Yoko Warabi

Since Specialization
Citations

This map shows the geographic impact of Yoko Warabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Warabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Warabi more than expected).

Fields of papers citing papers by Yoko Warabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Warabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Warabi. The network helps show where Yoko Warabi may publish in the future.

Co-authorship network of co-authors of Yoko Warabi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Warabi. A scholar is included among the top collaborators of Yoko Warabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Warabi. Yoko Warabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Warabi, Yoko, Tomoya Kawazoe, Ryo Morishima, et al.. (2020). Effects of oral care on prolonged viral shedding in coronavirus disease 2019 (COVID‐19). Special Care in Dentistry. 40(5). 470–474. 20 indexed citations
3.
Warabi, Yoko, Toshiyuki Takahashi, & Eiji Isozaki. (2019). Dimethyl Fumarate Was Ineffective but Not Harmful for a Patient with Myelin Oligodendrocyte Glycoprotein Antibody Disease. Cureus. 11(10). e6040–e6040. 2 indexed citations
4.
Warabi, Yoko, Yukiko Shishido‐Hara, Kazuo Nakamichi, et al.. (2019). Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis. Internal Medicine. 58(22). 3323–3329. 11 indexed citations
5.
Warabi, Yoko, et al.. (2018). Intracranial hemorrhagic lesions in neurosarcoidosis: The difference from neuromyelitis optica spectrum disorders. Clinical and Experimental Neuroimmunology. 9(S1). 60–62.
6.
Warabi, Yoko, Kentarō Hayashi, Masahiro Nagao, & Toshio Shimizu. (2017). Marked widespread atrophy of the cerebral cortex and brainstem in sporadic amyotrophic lateral sclerosis in a totally locked-in state. BMJ Case Reports. 2017. bcr2016218952–bcr2016218952. 6 indexed citations
7.
Warabi, Yoko, Toshiyuki Takahashi, & Eiji Isozaki. (2015). Progressive cerebral atrophy in neuromyelitis optica. Multiple Sclerosis Journal. 21(14). 1872–1875. 6 indexed citations
8.
Warabi, Yoko, et al.. (2014). Two cases of acute myelitis with idiopathic hypereosinophilic syndrome. BMJ Case Reports. 2014. bcr2014204326–bcr2014204326.
9.
Warabi, Yoko, et al.. (2012). Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement. Journal of Clinical Pharmacy and Therapeutics. 37(6). 724–725. 11 indexed citations
10.
Warabi, Yoko. (2011). Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese Multiple Sclerosis. PubMed. 2011. 1–4. 2 indexed citations
11.
Mochizuki, Yoko, Toshio Mizutani, Yoko Warabi, Toshio Shimizu, & Eiji Isozaki. (2008). The somatosensory cortex in multiple system atrophy. Journal of the Neurological Sciences. 271(1-2). 174–179. 6 indexed citations
12.
Nakashima, Ichiro, Toshiyuki Fukazawa, Kohei Ota, et al.. (2007). Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. Journal of Neurology. 254(4). 488–492. 28 indexed citations
13.
Koide, Reiji, et al.. (2007). [Homonymous visual field defect due to optic tract involvement in a patient with multiple sclerosis].. PubMed. 59(12). 1390–1. 1 indexed citations
14.
Warabi, Yoko. (2007). Role of IL-1 and potential therapies in multiple sclerosis. Drug Discovery Today Therapeutic Strategies. 4(1). 19–24. 5 indexed citations
15.
Warabi, Yoko, Yoh Matsumoto, & Hideaki Hayashi. (2006). Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. Journal of the Neurological Sciences. 252(1). 57–61. 132 indexed citations
16.
Warabi, Yoko, et al.. (2006). Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis. Journal of the Neurological Sciences. 249(2). 145–152. 22 indexed citations
17.
Warabi, Yoko, et al.. (2005). Cerebral Infarctions and Brain Abscess due to Lemierre Syndrome. Internal Medicine. 44(6). 653–656. 36 indexed citations
18.
Warabi, Yoko, Shiro Matsubara, Toshio Mizutani, & Hideaki Hayashi. (2004). [Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection].. PubMed. 44(9). 609–14. 11 indexed citations
19.
Warabi, Yoko, et al.. (2003). Triphasic Waves Detected during Recovery from Lithium Intoxication. Internal Medicine. 42(9). 908–909. 3 indexed citations
20.
Warabi, Yoko, et al.. (2002). Procerus Sign in Corticobasal Degeneration.. Internal Medicine. 41(12). 1217–1218. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026